Statement : According to the latest issue of the medical journal Lancet, Multidrug Resistant-Tuberculosis (MDR-T

• B , a version of the disease where patients do not respond to first-line drugs, will become more common than it is now. Course of Action: I. The National TB Programme should consider expanding beyond earlier public private engagement programmes to create new and sustainable partnerships that can help effectively monitor the activities, diagnosis and treatment in the private sector. II. Government should create awareness programs to educate people about how the transmission, diagnosis and treatment of Multidrug Resistant-Tuberculosis (MDR-T
• B